St. Jude Medical upgraded at RBC Capital As noted earlier, RBC Capital upgraded St. Jude Medical to Sector Perform from Underperform. After conducting a survey, the firm does not expect concerns about the durability of the company's Durata lead to significantly impact the company's results in 2014. Target to $64 from $44.
News For STJ From The Last 14 Days
Check below for free stories on STJ the last two weeks.